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Environmental Factors Altering Thyroid
Function and Their Assessment
by Charles P. Barsano*t
Chronic ingestion of modest doses of dietary iodine, radiation, and polyhalogenated
biphenyls (PCB's and PBB's) are environmental factors with known or suspected adverse
effects on the human thyroid. Iodine consumption in the United States is approaching 1 mg
daily for a large segment of the population. Data are reviewed which support the need for
concern regarding the long-term adverse effects of dietary iodine on thyroid function,
particularly in certain susceptible individuals. Environmental sources of radiation pose a
significant risk ofthyroid cancer and hypothyroidism under certain circumstances which may
be intentional, inadvertent, or accidental. Exposure to polyhalogenated biphenyls during
manufacture or as industrial pollutants are hazardous to man and to wildlife in moderate or
large quantities and perhaps also in small amounts. The need to investigate the potential harm
posed by these factors in the quantities commonly encountered is emphasized.
A wide variety of environmental agents adver-
sely affect the thyroid gland. Some have been
precisely identified while others are not well char-
acterized. Some are known to alter thyroid function
under unusual circumstances, but are only suspect
in the quantities ordinarily encountered. This re-
view will be limited to several agents whose occur-
rence within the environment is a by-product of
technology and whose effects may potentially ex-
tend to a large number of people. Initially, the
adverse effects of environmental toxins on thyroid
function will be discussed with emphasis on their
clinical and laboratory evaluation. Subsequent sec-
tions of this review will concern the adverse thyr-
oidal effects, proven or suspected, ofmodestly high
dietary iodine consumption, environmental sources of
radiation, and polyhalogenated biphenyl exposure.
Assessment of Thyroid Toxicity
Categorically, the major thyroidal abnormalities
include hypothyroidism, hyperthyroidism, goiter,
and carcinoma. Environmental agents which ad-
versely affect the thyroid assume clinical impor-
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tance by their ability to induce any one or more of
these problems. None are unique to environmental
toxins and consequently evaluation of suspected
environmental toxin-related thyroid disease pro-
ceeds along the same diagnostic routes as does the in-
vestigation ofspontaneously occurring thyroid disease.
Hypothyroidism is suggested clinically by inex-
plicable fatigue, cold intolerance, menstrual irregu-
larities, or constipation, among a wide variety of
other nonspecific symptoms. A goiter may be
present on physical examination. Hyperthyroidism
is characterized by nervousness, weight loss, heat
intolerance, or palpitations, among other symp-
toms. A goiter ornodularthyroid is usually present
on examination. Smooth or nodular goiters are
associated with a variety ofthyroid diseases and do
not imply concurrent hypofunction or hyperfunc-
tion. Ifpresent, symptoms are usually attributable
to hypo- or hyperthyroidism. Large goiters may
pose cosmetic problems or present with symptoms
suggestive oftracheal compression. Thyroid cancer
is considered in the differential diagnosis of a
palpable thyroid nodule; positive diagnosis is made
histologically after biopsy or surgical excision.
Thyroid cancer patients are generally euthyroid
and asymptomatic.
The laboratory evaluation of subjects with sus-
pected thyroid dysfunction, goiter, or potentially
malignant nodules is illustrated in Figure 1. Serum








FIGURE 1. Laboratory evaluation ofthyroid dysfunction, nod
ules, or goiter.
or free T4 index (FTI), and serum antithyroid
antibody titers are useful in the evaluation of all
patients with suspected thyroid dysfunction, goi-
ter, or thyroid nodules. The T4, T3, and FTI may
confirm the suspicion of hypothyroidism or hyper-
thyroidism, or reveal clinically inapparent degrees
of hypothyroidism or hyperthyroidism. Primary
hypothyroidism, as opposed to the hypothyroidism
ofpituitary insufficiency, is confirmed by the finding
of an elevated serum thyrotropin (TSH) level. The
determination of thyroid function in subjects pre-
senting primarily with goiter or thyroid nodules is
important because mild hypo- or hyperthyroidism
is often not clinically obvious but would neverthe-
less influence the etiological considerations in sub-
jects with goiters or thyroid nodules. The presence
of antithyroid antibodies strongly favors a diagno-
sis of chronic lymphocytic thyroiditis (Hashimoto's
disease) in hypothyroid patients or diffuse toxic
goiter (Graves' disease) in hyperthyroid patients.
Positive antibody titers in seemingly euthyroid
patients with goiters is suggestive of early or very
mild Hashimoto's or Graves' disease. Elevated
antibody titers in patients presenting with a small
thyroid nodule would suggest that the nodule may
represent a palpable irregularity of the thyroid com-
monly found amongpatients with Hashimoto's disease.
Technetium or 123I thyroid scans are useful in the
evaluation of hyperthyroid patients to distinguish
diffuse toxic goiter from toxic adenoma or toxic
multinodular goiter. These scans are also useful in
the evaluation of goitrous patients to help discrim-
inate diffuse goiters from multinodularglands whose
structure may be more apparent on the scan than
on examination. A thyroid scan is particularly
useful in the evaluation ofthyroid nodules. Palpable
malignant nodules are usually hypofunctional and
appear as relatively inactive areas on the scan.
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Thyroid cysts and benign adenomata may also
appear as scintographically hypofunctional areas.
With occasional exceptions, functioning nodules are
benign. Additional diagnostic information is offered
bythe degree ofthyroid nodularity. A single nodule
in an otherwise normal thyroid is more likely to be
malignant than a nodule in a uniformly multinod-
ular gland.
Ultrasonagraphy (1) is a valuable noninvasive
diagnostic technique for distinguishing solid thy-
roid nodules from simple cysts, the latter being
much less likely to be malignant. Needle aspiration
biopsy (2) yields much the same information plus
additional cytological data concerning the malig-
nant potential of the cells.
A radioactive iodine uptake (RAIU) determina-
tion is often useful in the evaluation of hyperthy-
roidism. Factitious hyperthyroidism (self-induced
by excessive thyroid hormone ingestion) and "si-
lent" or "painless" thyrotoxicosis (3-5) are accom-
panied by a very low RAIU, whereas the more
common forms of hyperthyroidism are associated
with normal or elevated RAIU's.
The primary discriminants of toxin-related thy-
roid disease are historical and epidemiological. On
an individual basis the onset of detectable thyroid
abnormalities must be carefully considered with
respect to the earliest exposure to the suspected
toxin. Similarly, the amelioration of symptoms
should be considered in terms of the time after
cessation of exposure. On a statistical basis the
type and prevalence of the suspected thyroidal
abnormality within an exposed population should
be compared to these same parameters in a compa-
rable but unexposed population.
A family history ofthyroid disease should always
be obtainedfromindividuals suspected ofenvironment-
related thyroid disease. Dyshormonogenetic goi-
ters and autoimmune thyroid diseases exhibit sign-
ificant hereditary predispositions. Their recogni-
tion may suggest that the suspected thyroid
abnormality pre-existed the toxic exposure and was
induced to become clinically apparent. Certain
individuals may be essentially free of disease prior
to exposure but are more susceptible to developing
thyroidal abnormalities in response to toxic insults
than ordinary individuals.
Chronic Ingestion of Modest Doses
of Dietary Iodine
Prior to dietary iodine prophylaxis, goiter, hypo-
thyroidism, and cretinism from iodine deficiency
had been endemic in many areas of the world. In
many areas these problems still exist (6). In the
United States, goiter had been particularly preva-
Environmental Health Perspectiveslent alongthe northern border ofthe country and in
the upper midwestern states. Since the introduc-
tion of iodized salt in these areas in the 1920's (7),
the prevalence of goiter has been dramatically
reduced (8). By 1970, daily iodine consumption in
the U.S. ranged from 238 ,ug to 738 ,ug (9), as
calculated from its effects on the normal ranges of
radioiodine uptakes at various centers around the
country. Daily iodine consumption in endemic
iodine-deficiency areas estimated by direct assay of
iodine in 24-hr urine specimens is usually less than
50 ,ug. The U.S. Recommended Dietary Allowance
(RDA) for iodine has most recently been set at 150
jig daily for adults plus an additional 25 ,ug and 50
,ug for pregnant and lactating women, respectively
(10). Consistent with these determinations, iodine-
deficiency in this country is no longer a public
health problem.
To the contrary, more recent estimates of daily
iodine consumption in the U.S. and Canada indicate
that iodine consumption is clearly above the RDA
and for most people substantially above the RDA
(Table 1). A study of children aged 9-16 in Michi-
gan, Kentucky, Texas, and Georgia in 1971-72
revealed an average iodine intake of459 jig per day
(11). An extensive study in 1968-70 covering 36,000
people in ten states revealed that 9.5-21.9% of the
people tested excreted in excess of 799 ,ug iodine
per gram ofurinary creatinine per day in 7 ofthe 10
states (12). As approximately one-half of the stud-
ied population in the seven states were adults
[estimated to excrete approximately 1.2 g (females)
to 1.5 g (males) creatinine per day], it can be grossly
estimated that 5-10% of the test population, or
10-20% ofthe adults, consumed over 1 mg ofiodine
per day. A 1970-72 nutritional survey of Canada
revealed that approximately 5% of the adult popu-
lation consumed 500-700 jig iodine/g urinary creati-
nine, or in the order ofapproximately 0.8 mg iodine
per day. Perhaps 2% ofthe population consumed in
excess of850 ,ug iodine/g creatinine, or in excess of
1 mg of iodine per day (13). Over 15 years ago,
healthy individuals near Washington, D.C. were
calculated to consume over 0.8 mg of iodine daily,
ranging up to 1.5 mg per day, on 20% of days
studied (14). Analysis of the adult Market Basket
Surveys of 1974 and 1975 indicate an average daily
iodine intake of 784 ,ug and 642 jig, respectively, in
those consuming a2800 calorie diet (15). Addition of
260 jig ofiodine from 3.4 g ofiodized table salt (16)
brings the average daily iodine intakes to approx-
imately 1 mg per day. As a result of the studies
involving direct measurement of plasma or urinary
iodide and the observations ofprogressively declin-
ing nor-mal ranges for ra(lioactive io(line uptakes (I -
19), the tren(c toward increase(l iodline consuml)tioi
in the U.S. has Inot goine unlrecognize(d (15, 20-2,;).
Although it is very difficult to project an esti-
mated average daily iodine consumption for chil-
dren and for adults in the U.S. in 1980, it is
probably fair to assume that at least 10% of the
adult population, and possible much more, consume
in excess of 1 mg iodine per day and that a
comparable percentage ofchildren may be consum-
ing an iodine load proportionate by body weight to
the adult consumption. Since it can be calculated
that approximately 260 jig of iodine are consumed
daily in table salt iodized at the 1:10,000 level (100
jig KI/g salt or 75 jig iodide/g salt), it becomes
apparent that most ingested iodine is obtained from
less obvious dietary sources (16). Ingestable iodine
is commonly found in a wide variety of foodstuffs,
food coloring and seasonings, food processing ag-
ents, and medicaments. The bulk ofdietary iodine,
however, is probably derived from milk and other
dairy products and from bread prepared with
iodate as a dough conditioner (15). The many and
diverse uses for iodine in the food and dairy
industry give reason to suspect that dietary sources
of iodine are not likely to decline until an equally
diverse group of alternative agents are identified
and implemented.
At present it is impossible to be certain that
chronic ingestion of modest amounts of iodine
would have adverse effects on thyroid function
although there is considerable evidence that sup-
ports the wisdom for concern. If even a few percent
of the population ingest in excess of 1 mg of iodine
Table 1. Estimates of high iodine intakes among adults.
Study Source Year Estimate
Washington, D.C. Suburbs Vought and London (14) 1964 > 0.8 mg on 20% of
Vought (20) days sampled
Ten-State Nutritional Survey Trowbridge et al. (12) 1968-70 ¢ 1 mg in 10-20%a
Saskatchewan Survey Nutrition Canada (13) 1970-72 ¢ 0.8 mg in 5%
Market Basket Survey Harland et al. (15). 1974 1 mg (average)b
Market Basket Survey Harland et al. (15) 1975 0.9 mg (average)b
a In seven ofthe ten states, assuming that the finding ofurinary iodine excretion > 799 ,ug/g creatinine per day was equally common
in adults and children.
b For adults consuming a 2800 kcal diet including 3.4 g of iodized salt daily.
April 1981 73FIGURE 2. Adverse effects of iodine reported in susceptible
individuals. Iodine in varying dosages (A) has been intro-
duced into societies accommodated to different levels ofdaily
iodine consumption (B) resulting in adverse effects (C) in
normal individuals (NL); neonates (Neo); patients with
subclinical autonomously-functioning nodules (Sub-AN), Graves'
disease (Sub-Gd) or Hashimoto's disease (Sub-Hd); patients
with Graves' disease previously treated with radioactive
iodine (Gd-RAI) or by subtotal thyroidectomy (Gd-STx); and
patients previously treated for benign thyroid nodules by
partial thyroidectomy (PTx).
daily, substantial numbers of people are involved.
Certain potentially susceptible groups of people,
e.g., the unborn and those with subelinical thyroid
disease, may face a slight but unrecognized risk
from quantities ofiodine too little to affect ordinary
individuals. As depicted in Figure 2, interpretation
of the large body of data relevant to the adverse
effects ofiodine on thyroid function requires appre-
ciation of the baseline daily iodine ingestion of the
subject population, the daily quantity of iodine to
which the subject population is being introduced,
the rate ofintroduction ofincreased levels ofiodine
into the population, the presence and nature of any
underlying susceptibilities to overt thyroid dys-
function, and the type of thyroid abnormalities
reported to result from the exposure.
There are numerous reports of iodine-induced
hyperthyroidism (Jod-Basedow phenomenon) when
iodine, sometimes in quantities less than 1 mgdaily
(24), were introduced into iodine-deficient popula-
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tions (25, 26). Subsequent study (27) support the
theory that the induced hyperthyroidism is a mani-
festation of underlying autonomously-functioning
thyroid nodules orGraves' disease. Assumedly, the
underlying disease had been silent only for lack of
available substrate for thyroid hormone produc-
tion. Administration ofordinary amounts ofiodine
(several hundred ,ugperday) to subjects in areas of
minimally adequate quantities of dietary iodine,
e.g., parts ofwestern Europe, has been reported to
induce hyperthyroidism in subjects with nodular
thyroids (28) and in some individuals without ap-
parent underlying thyroid disease (29). It does not
follow, however, that this phenomenon would be
reproduced by superimposing comparably small
amounts of iodine on a population which has been
chronically exposed to more than adequate sources
of iodine.
There are reports of thyroid dysfunction arising
in subjects living in iodine-sufficient areas (greater
than 100 ,ug iodine per day). With very few
exceptions the reported cases involve administra-
tion ofpharmacological doses ofiodine, here regar-
ded as greater than 10 mg per day but generally in
excess of 100 mg per day. Ingestion of large
quantities of iodine by pregnant women is well
known to induce goiter (30, 31) and less commonly
hypothyroidism (31, 32) in the fetus. At times these
goiters have resulted in tracheal compression and
neonatal asphyxiation. Normal individuals are also
at a small but definite risk ofdeveloping goiter and
occasionally hypothyroidism during chronic inges-
tion ofpharmacological doses ofiodine (30, 33, 34).
Perhaps most well known are the residents of
coastal areas of Hokkaido, Japan who consume
8-200 mg of iodine per day (35). School children of
these areas maintain a 25% prevalence of goiter.
Patients with chronic obstructive pulmonary dis-
ease (36) or cystic fibrosis (37) treated with 450 mg
ofiodine or more per day have been reported to de-
velop goiter, often associated with hypothyroidism.
Hypothyroidism has also been described as a
primary consequence ofthe administration oflarge
doses of iodine to euthyroid individuals in iodine-
sufficient areas. Four of seven euthyroid patients
with underlying Hashimoto's thyroiditis became
hypothyroid within4-6weeks oftreatmentwith 180
mg ofiodine per day (38). Patients with hyperplas-
tic or regenerating thyroid tissue as seen after
partial thyroidectomy for thyroid nodules (39) or
Graves' disease (33, 38) or after radioactive iodine
therapy of Graves' disease (33, 40, 41) have also
been shown to become hypothyroid after the
administration of large doses of iodine.
The induction of hyperthyroidism in iodine-
sufficient individuals by large doses of iodine has
Environmental Health Perspectivesalso been reported. Patients with euthyroid nodu-
lar goiters have been shown to become hyperthy-
roid after several weeks oftreatment with 180 mg
iodine per day (42). An asthmatic child with a
familyhistoryofgoiterandhyperthyroidism, treated
with well over 1000 mg of iodine per day, was
observed to become thyrotoxic within four months
of initiation of treatment and improved promptly
after discontinuation ofthe medication (43). Iodine
derived from radiographic contrast media has also
been reported to induce hyperthyroidism in a
patient with anontoxic, autonomous thyroid nodule
(44). But the potential for pharmacological doses of
iodine to induce goiter, hypothyroidism or hyper-
thyroidism in iodine-sufficient healthy individuals,
or even in susceptible individuals, may not neces-
sarily be applicable to modest doses ofiodine in the
1-10 mg per day dosage.
It should be noted that relatively small doses of
0.5 mg iodine are capable of inducing abnormal
perchlorate discharge tests in some euthyroid pa-
tients with mild Hashimoto's disease (38, 45) and
that this characteristic may identify which ofthese
patients are prone to become hypothyroid after
treatment with large doses ofiodine (38). The same
phenomenon has been observed in euthyroid pa-
tients previously treated with radioactive iodine for
Graves' disease (33). It does not follow, however,
that chronic exposure of patients with subclinical
disease to a diet incremented by 0.5 mg of iodine
per day would necessarily lead to clinically appar-
ent disease. Interestingly, this dose of iodine has
been alleged to induce hyperthyroidism in one
patient within several weeks (46).
The effects on thyroid function of chronic iodine
consumption in the 1-10 mg per day range have not
been adequately investigated. A most informative
study concerning this topic involves a prison popu-
lation whose source ofdrinkingwater contained 0.5
mg/l. ofiodine as adisinfectant (47,48). Dailyiodine
consumption was probably in the order of 1-2 mg
daily forup to 3 years. Not surprisingly, their24-hr
radioactive iodine uptakes dropped from an aver-
age of 17% to 7.2% without change in the serum
thyroxine levels. No cases ofgoiter orhypothyroid-
ism were thought to result from this exposure,
although four inmates who may have had mild
symptoms of hyperthyroidism when entering pri-
son became frankly thyrotoxic during their impri-
sonment. Two patients exhibited elevations in their
serum thyroxine levels after discontinuing the
water, but normalized their thyroxine levels when
again exposed the water. Importantly, no neonatal
goiters or increased incidence ofcongenital anoma-
lies were observed in 181 full-term neonates of
imprisoned mothers.
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The findings of several studies suggest that
increases in iodine consumption may favor induc-
tion of Hashimoto's thyroiditis. The prevalence of
histologic thyroiditis in thyroidectomy specimens
appears to have increased after the introduction of
iodine prophylaxis in the United States (49-51).
Lymphocytic thyroiditis was rarely found in thy-
roid specimens of untreated patients with iodine-
deficiency goiters in the Himalayas (52). Adminis-
tration of large amounts of iodine to rats and
hamsters has been reported to induce lymphocytic
infiltration ofthe thyroid (53, 54). Addition ofiodine
to immunogenic preparations of thyroid extracts
has also been shown to induce a histologically more
humanlike lymphocytic thyroiditis in beagles (55).
However, the animal models may not be equivalent
to the human disease. The prevalence of physical
and laboratory features of Hashimoto's thyroiditis
and Graves' disease in contemporary school chil-
dren (11, 56, 57) is surprisingly high but not ofitself
indicative of a causative or exacerbating role for
iodine. These and other studies have been pre-
viously considered with the general impressionthat
the evidence for a role ofiodine in the pathogenesis
of chronic lymphocytic thyroiditis remains incon-
clusive (23).
The induction by iodine ofgoiter orabnormal 131I
uptake and perchlorate discharge tests in patients
with Hashimoto's thyroiditis rather argue that
these patients are particularly susceptible to the
adverse effects of iodine, perhaps less capable of
escaping the Wolff-Chaikoff block (58). It has been
suggested that iodides enhance a pre-existing intra-
thyroidal organification defect in patients with
Hashimoto's thyroiditis (59).
Other adverse effects of modest iodine ingestion
have been suggested. The increasing consumption
ofiodine over the 10-year period from 1962 to 1972
has been hypothesized to effect a reduction in the
remissionrateofantithyroiddrugtherapyofGraves'
disease (60). Administration of iodine to patients
withdrawn from antithyroid drugs has had some-
what conflicting effects on remission rates (61, 62).
The relatively high incidence of papillary thyroid
cancer in Iceland and Japan, two countries with
relatively high daily iodine consumption, has been
pointed out (63, 64), but the putative association of
thyroid cancer and increased iodine consumption is
open to other interpretations (23). Acne, ioderma,
and a wide variety ofadverse effects not related to
the thyroid have been thoroughly reviewed else-
where (65).
At present the evidence that chronic iodine
intake in the order of 1-10 mg daily presents a
significant risk of thyroid dysfunction is largely
circumstantial but, in view of the size of the
75potential target population, the trend toward in-
creased iodine consumption, and the more probable
success of earlier rather than later intervention,
the question merits serious evaluation. This issue
has, in fact, been the topic of a recent workshop
(66). Recommendations forthcoming from this wor-
kshop are anticipated to include an appeal to limit
further increases in dietary iodine input until the
biological safety ofchronic, modest iodine ingestion
is more firmly established.
Environmental Sources of
Radiation
There is little doubt that under appropriate
circumstances radiation exposure can induce a
variety ofthyroid-related abnormalities. Treatment
of hyperthyroid patients with 131I has been ob-
served to exacerbate the hyperthyroidism (67, 68),
presumably by releasing stored hormone from
radiation-damaged tissue. There are numerous re-
ports ofprimary hypothyroidism arising after radi-
ation exposure to the thyroid (69, 70). High radia-
tion doses (> 1,000 rem) to the thyroid administered
as 131I for the treatment ofGraves' disease (40) and
cardiac disease (71, 72), or as external radiation to
the head and neck for regional carcinoma (69, 70,
73) are known to induce hypothyroidism particu-
larly at very high dosages (> 25,000 rem). Expo-
sure to external radiation less than several hundred
rem appears to involve very little risk of hypothy-
roidism (74-76), although a threshold as low as 20
rem has been suggested (69) for 131I exposure.
Induction ofthyroid cancer by radiation has been
considered under a wide variety of circumstances.
As outlined in Table 2, radiation exposure can be
intentional, inadvertent, or accidental. Intentional
destruction ofthyroid tissue with administration of
131I is a common and effective therapy for Graves'
disease and was formerly used for the amelioration
ofanginapectoris (71). In smaller doses 131I and 123I
are often used in diagnostic thyroid scans and
uptake measurements. Typical thyroidal radiation
Table 2. Sources of thyroidal radiation exposure.
Type Source
Intentional Treatment of Graves' disease with 1311
Treatment of angina pectoris with 131I
Diagnostic thyroid scanning with 131I or 23I
Inadvertent Radiotherapy of head and neck cancer
Radiotherapy of benign diseases
Atom-bomb blasts (Hiroshima and
Nagasaki)




Table 3. Approximate thyroidal radiation exposure from
isotopes of iodine.
Procedure Dose Exposure (rads)a
131I treatment of angina 30 mCi 30,000
1311 treatment of Graves' disease 5mCi 5,000
311 scan 50,uCi 50
131I uptake 6 1Ci 6
3I scan 300 ,uCi 2
123I uptake 50 ,uCi 0.4
99mTc scan 3000,uCi 1
aRads are equivalent to rems for radioisotopes of iodine.
exposures fromthese procedures are given in Table
3. Thyroid exposure to radiation also occurs inad-
vertently. Significant thyroid exposure to radiation
results from radiotherapy forlymphomas and other
carcinomas ofthe head and neck, and from the now
discontinued use ofradiation for tonsillar or thymic
enlargement, acne, pertussis, and tinea capitis
among other benign illnesses (77). Inadvertent
exposure from both external radiation and from
inhaled or ingested 131I has been studied in those
exposed to nuclear weapon testing (75, 78-80) and
to the survivors of the Hiroshima and Nagasaki
blasts (81, 82). Accidental exposure to the radioiso-
topes of iodine has long been a risk to laboratory
workers and technicians and, as recently drawn to
wide public attention (83), may pose a risk to many
after nuclear reactor accidents.
Radiation exposure to the thyroid in excess of
approximately 25,000 rem involve a significant risk
of inducing hypothyroidism but seems to involve
minimal risk of carcinogenesis when employed for
the relief of cardiac disease (69, 84, 85). Expec-
tedly, lethal doses of radiation would greatly re-
duce the population of cells available for carcinog-
enesis. The lesser degree of radiation exposure to
the thyroid involved in the treatment of Graves'
disease with 1311, generally 5,000-10,000 rem, sim-
ilarly does not appearto involve asignificant risk of
carcinoma. A number of studies (86-89) indicate
that carcinogenesis is not a significant risk at doses
in excess of approximately 2000 rem, and that 131I
therapy for Graves' disease does not impose a risk
of carcinogenesis (85, 90, 91).
Radiation exposure from diagnostic 131J thyroid
scans is considerably less than therapeutic expo-
sure but is perhaps not insignificant. A 50 ,Ci "I
scan would deliver an approximate exposure of 80
rem to an adult thyroid and two or three times that
to a child's thyroid (92). The studies ofRallison and
others (75, 79) on the schoolchildren exposed to
comparable amounts ofradiation from nucleartest-
ing suggests that 50-100 rem may approximate the
threshold below which there is no appreciable risk
of carcinogenesis. One case of thyroid carcinoma
Environmental Health Perspectivesfollowing diagnostic studies has been reported (93).
Available information suggests that 131Iscans ap-
proach the exposure level thought to pose a proba-
ble though small risk of carcinogenesis.
Radiation therapy oflymphomatous cervical lymph
nodes or other carcinomas ofthe head and neckmay
involve considerable exposure to the thyroid, often
enough to result in primary hypothyroidism (70).
Anecdotal cases of thyroid cancer in patients pre-
viously subjected to radiotherapy of head or neck
carcinoma have been noted in several reports and
letters (94-99) as well as in the author's own
experience. Likely, the generally higher radiation
exposure and older age of those subjected to
radiotherapy of head or neck malignancy account
for the lower incidence of thyroid cancer in these
patients.
In the 1940's and 1950's low-dose radiotherapy
was commonly used for a variety of benign prob-
lems of infancy and childhood (77). Depending on
the dose of applied radiation and the proximity of
itsfield to the anteriorneck, thyroid exposure could
range from virtually nil to over a thousand rem. It
was subsequently observed that children with thy-
roid cancer had a frequent history ofpriorradiation
for benign problems (100-102). Since then, numer-
ous reports have confirned the association of low-
dose radiation exposure and thyroid cancer (76,
103-106). Analysis ofseveral studies demonstrate a
dose-dependent risk of post-radiation carcinogen-
esis up to approximately 1000-1500 rem (69, 86,
107). It is unclear if radiation exposures below 20
rem are associated with a risk of carcinoma (74).
The latent period for detection of thyroid carcino-
mas after radiation exposure is generally ten or
more years and may extend up to or beyond 40
years (76, 86, 97, 108-110).
Radiation exposure from nuclear weapons in-
cludes both direct, external radiation and exposure
from absorbed or ingested radioisotopes of iodine
(particularly 1311) derived from the fallout. Survi-
vors ofthe Hiroshima and Nagasaki A-bomb blasts
studied 13-16 years after exposure were not found
to exhibit a greater prevalence of thyroid cancer
when compared to a contemporary non-exposed
clinic population, although the prevalence of thy-
roid cancer among the exposed patients appeared
to be inversely proportional to their distance from
the hypocenter of the blast (82). In a subsequent
study (81) of the A-bomb survivors 13-26 years
after the blasts, the prevalence of thyroid cancer
was indeed found to be higher in all those exposed
to 50 or more rads of radiation, particularly if the
individuals were less than 20 years of age at the
time of exposure.
Of 67 Marshall Islanders inadvertently exposed
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to direct gamma-radiation and to 131I, 132i, 133i, and
135I fallout, 21 developed thyroid abnormalities
including three malignancies, 16 benign nodules,
and two cases of hypothyroidism (78). The adult
exposure on the first day was in the order of 160
rads from 131I and 175 rads from gamma-radiation.
Children under age 10 seemed to have a much
higher propensity to develop a thyroid abnormali-
ty, possibly as a result of their generally threefold
higher radioiodine exposure. It may also be true
thatthyroid tissue in childrenismore susceptible to
radiation damage than adult tissue (111).
Infants and children aged 8 or less at the time of
exposure to the fallout in southwestern Utah fol-
lowing the Nevada nuclear weapons tests in the
early 1950's were found to have no greater preva-
lence of thyroid nodularity than a control, nonex-
posed population (79). The target population was
studied approximately 10 years after an estimated
thyroid exposure of 5-50 rads and perhaps more
than 100 rads in some cases. Radiation exposure
from the Nevada tests was thought to be largely
acquired from 131I-contaminated milk. Minute doses
of radioactivity have also been detected in fetal
human thyroids after maternal exposure to 1311.
containing fallout from the nuclear weapons testing
in 1958bythe United States, Great Britain, and the
Soviet Union (112).
Accidentalingestion of1311 or 125I has occurred in
laboratory technicians during radio-iodination pro-
cedures for labeling proteins. Ingested doses could
range from the trivial to several millicuries. The
latter situation would to some extent mimic the
treatment of Graves' disease although iodine turn-
over and tissue sensitivity to radioiodine would be
lower in normal thyrroid glands. In a study compar-
ing the efficacy of I25 treatment ofGraves' disease
to that of 131I, the former isotope resulted in a
greater degree of hypothyroidism (113).
Nuclear reactor accidents have the potential of
exposing many people to significant amounts of
thyroid radiation exposure. Huge amounts of vola-
tile and water-soluble radioisotopes ofiodine can be
generated, of which 131J and 133I are the most
important (114). Fortunately, in the recent mishap
at the Three Mile Island Nuclear Station in March,
1979, the preponderance of radioiodine isotopes
was well contained. In a preliminary study (83) in
which milk samples in the immediate area were
assayed for 131i, only one-fourth of the samples
contained the isotope in concentrations ranging
from 1-41 pCi/l. It was calculated that an infant
drinking 1 liter of the most heavily contaminated
milk would be subjected to 5 mrem of thyroidal
radiation; an adult consuming the same quantity
would be subjected to only one-tenth that amount.
77These exposures are well below the estimated
annual total body radiation exposure from unavoid-
able sources of cosmic and terrestrial radiation.
Estimated 13"I intake from the air was similarly
miniscule.
Radiation-associated hyperthyroidism, hypothy-
roidism, and carcinogenesis are not clinically dis-
tinct from the spontaneously occurring thyroid
diseases. Except perhaps for the histological fea-
tures of radiation-fibrosis or radiation-thyroiditis,
the etiology of the radiation-associated thyroid
abnormalities become apparent only by uncovering
the historical and epidemiological features ofradia-
tion exposure in affected individuals.
Polyhalogenated Biphenyls
Polyhalogenated biphenyls are commonly used
compounds with a wide variety of industrial appli-
cations. Polybrominated biphenyls (PBB's) have
been used as flame retardants. Polychlorinated
biphenyls (PCB's) are used as lubricants, adhe-
sives, inks, hydraulic fluids, and as plasticizers
(115). The environmental impact of the PCB's
derives from their presence as pollutants in lakes
and rivers and their capacity to accumulate in the
adipose tissue of fish and fish-eating predators,
including man (115). There is little question thatthe
PCB's affect the thyroid function of animals. Ex-
tensive (116-118) and brief reviews (119) of the
social and biological impact of the PCB's are al-
ready available, and so this review will focus
primarily on the studies pertinent to the potential
adverse effects on human thyroid function.
The preponderance of animal data implicate the
PCB's as inducers of goiter and hypothyroidism.
Coho salmon from the Great Lakes have exhibited a
high prevalence ofgoiter in recent years (120-122).
The very low iodine content of the Great Lakes
compared to sea water (123) is probably partially
responsible for the goiters in these fish. It has been
demonstrated decades ago that rainbow lake trout
were more commonly goitrous than those found off
California (124). Recent analysis reveals that the
frequency of Coho salmon goiter is not inversely
proportional to the iodine content ofthe lakes from
which the Coho were obtained (122). Further, the
incidence of goiter among the Coho population
appears to be increasing in recent years, whereas
the iodine content ofthe water is essentially stable.
These observations are consistent with the inter-
pretation that the increasing incidence of goiter
reflects increasing lake pollution (not necessarily
limited to PCB's). It has also been shown that
PCB's are capable of inducing thyroid abnormali-
ties when fed to Coho (123). As consumers ofother
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fish, and perhaps being less well adapted to a low
iodine environment than fish indigenous to the
Great Lakes, the Coho are more likely to accumu-
late fat-soluble goitrogens and may be more suscep-
tible to goitrogenesis. In addition to goiter, the
Coho have exhibited markedly depressed thyroxine
and triiodothyronine levels (121). Histological fea-
tures suggestive of thyroid cancer have also been
reported (120).
The molecular mechanisms of PCB-induced goit-
rogenesis and hypothyroidism have been systemat-
ically studied in rats cutaneously exposed to PCB-
containing immersion oil (125). Compared to
unexposed controls, the PCB-exposed animals ex-
hibited decreased serum thyroxine (T4) but not
triiodothyronine (T3) levels. It appeared that PCB
displaced T4 from the serum proteins, accounting
for the low total T4 levels. Additionally, increased
biliary excretion and loss of T4, possibly related to
the induction of T4-UDP-glucuronyl transferase,
may have contributed to the simultaneously re-
duced free T4 index. Enhancement ofperipheral T4
to T3conversion was thoughtto explainthe absence
of simultaneous reductions in the serum T3 level
and free T3 index. Thyroid enlargement has also
been observed in rats treated with PCB's (126) or
PBB's (127).
After long-term contact with PCB in more than
trace quantities, humans may develop an acnelike
skin rash, weakness, headaches, gastrointestinal
disturbances, irritation ofthe eyes, nose and throat,
swollen extremities, and many other symptoms
(128, 129). In 1968, over 1000 people in southwest-
ern Japan were afflicted with a syndrome, usually
beginning with a chloracnelike skin eruption now
known as Yusho disease. The epidemic was traced
to PCB-contaminated rice oil used for cooking
(129). Subsequently, 22 deaths were associated
with the PCB exposure, including nine malignan-
cies of various types (128). No specific thyroid
abnormalities were reported.
PCB is present at 5 mg/kgin lake fish (115) and is
also found in the adipose tissue of a surprising
30-45% of the general public (130, 131). It is
uncertain, however, ifthere are any adverse health
effects pursuant to this order of exposure. Hema-
tology technicians working with PCB-containing
microscope immersion oil exhibited no abnormali-
ties when screened for decreased serum T4 levels
and increased thyrotropin levels as indicators of
early hypothyroidism (125). A recent evaluation of
35 workers in a PBB manufacturing plant (132)
identified four cases of primary hypothyroidism,
whereas no cases were found among 89 control
subjects. These same four cases had markedly
elevated titers ofantithyroid microsomal antibodies
Environmental Health Perspectivessuggesting that the hypothyroidism was a manifes-
tation ofchronic lymphocytic thyroiditis, perhaps a
PBB-induced exacerbation ofpre-existing but sub-
clinical disease. There was not statistically signific-
ant difference in the prevalence of elevated anti-
microsomal antibody titers between the control and
exposed groups. PBB's also have been reported to
cause decreased serum T4 levels in rats (127).
In a subsequent report, 51 subjects were evalu-
ated who had been exposed to PBB's and found to
have abnormal serum or adipose levels of this
compound (133). Neither thyroid nodularity or
goiter, norunusual incidence ofabnormal serumT4,
thyrotropin or T3-resin uptake were found. As
suggested, the absence of abnormalities must be
viewed with the understanding that PBB's may
have a long latent period and falsely appear innocu-
ous. The evidence for harm by PCB and PBB
exposure in the quantities commonly encountered
by the average person is still inconclusive.
In parallel to the potential hazards perceived for
the chronic ingestion of modest amounts ofiodine,
individuals with greaterthan average exposure and
those with a greater susceptibility to the com-
pounds are likely to be the first to manifest goiter
or hypothyroidism.
Conclusion
The recurrent theme in the consideration of
iodine, radiation, or polyhalogenated biphenyls as
environmental thyroid toxins in the quantities com-
monly encountered is that there appears to be
abundant evidence for suspicion but scant evidence
for definitive conclusions. In part this may reflect
our intrinsically more rapid capacity to apply tech-
nology than to evaluate it, but also reflects the lag
phases from the introduction of an agent into the
environment to the uncovering of specific and
relevant questions concerning its impact, and from
the recognition of relevant questions to the deter-
mination ofthe answers. With each ofthese agents
it is hoped that the important questions concerning
their thyroid toxicity have been recognized and
that the answers will be adequately pursued.
This work was supported by U.S. Public Health Service
Grants AM-13377 and AM-06151.
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